Hidetoshi Masumoto

Hidetoshi Masumoto

Department of Cardiovascular Surgery, Kyoto University

Affiliated withKyoto UniversityRIKEN Center for Biosystems Dynamics Research

Research Area

Biography

Hidetoshi Masumoto graduated and received his medical degree from Kyoto University, Japan. He completed his Cardiovascular Surgery Residency at Kyoto University Hospital and Kumamoto Central Hospital and joined to Shizuoka City Hospital as a staff surgeon of the Department of Cardiovascular Surgery in 2002.

Besides his clinical career, Hidetoshi Masumoto started his research career from 2007 at the Department of Cardiovascular Surgery and Center for iPS Cell Research and Application (CiRA), Kyoto University and received a doctorate in medicine in 2012 for the researches about cardiac regeneration based on pluripotent stem cells and cell sheet technology. In 2013, he moved to Cardiovascular Innovation Institute, University of Louisville, Kentucky, USA as a postdoctoral fellow to expand his research for the clinical translation of biomimetic artificial heart tissues including human induced pluripotent stem (iPS) cell-derived cardiovascular cell lineages. In 2015, he returned to Kyoto University as an Assistant Professor at CiRA then moved to the Department of Cardiovascular Surgery, Kyoto University Hospital in 2016. In 2017, Hidetoshi Masumoto launched an independent research group as the Leader for Clinical Translational Research Program at RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japan in addition with the clinical position at Kyoto University Hospital.

Hidetoshi Masumoto’s research focuses on clinical translation of human iPS cell technology in cardiovascular medicine including cardiac regenerative therapy, disease modeling and drug discovery using bioengineered human iPS cell-derived cardiac tissues, development of the strategies for the improvement of the outcome of cardiovascular surgery using various animal disease models.

JoVE Journal Publications

ArticleTotal : 3
Year
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Publication title

Cited by 2

2018
2020
2020

Other Publications

Article
Year
Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularizat...

Stem cells (Dayton, Ohio)| PubMed ID: 22438013

2012
Cardiovascular surgery for realization of regenerative medicine.

General thoracic and cardiovascular surgery| PubMed ID: 22933086

2012
Prevention of retrosternal adhesion by novel biocompatible glue derived from food additives.

The Journal of thoracic and cardiovascular surgery| PubMed ID: 23582278

2013
2014
2014
2014
2015
2016
2016
2017
Human iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac Regeneration.

Current treatment options in cardiovascular medicine| PubMed ID: 27637492

2016
Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model.

The Journal of thoracic and cardiovascular surgery| PubMed ID: 27838010

2017
2017
2017
2017
Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.

The Journal of thoracic and cardiovascular surgery| PubMed ID: 28645823

2017
2017
2017
2018
2018
2018
2018
2018
2019
Chronic optical pacing conditioning of h-iPSC engineered cardiac tissues.

Journal of tissue engineering| PubMed ID: 31024681

2019
2020
2020
2020